Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis-associated refractory macrophage activation syndrome

Wu, JQ; Sun, L; Tang, XM; Zheng, Q; Guo, L; Xu, L; Li, YD; Lu, MP

Lu, MP (通讯作者),Zhejiang Univ, Childrens Hosp, Natl Clin Res Ctr Child Hlth, Dept Rheumatol Immunol & Allergy,Sch Med, 57 Zhugan Lane,Yan An Rd, Hangzhou 310003, Peoples R China.

MODERN RHEUMATOLOGY, 2022; 32 (6): 1114

Abstract

Objectives To evaluate the safety and efficacy of tocilizumab (TCZ) on refractory macrophage activation syndrome (rMAS) associated with systemic juven......

Full Text Link